Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Bedside HIV tests could uncover silent infections in hospital patients

NCT ID NCT06282328

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how many hospital patients have undiagnosed HIV. Researchers offered a rapid finger-prick HIV test to 300 patients who had certain medical conditions or behaviors that increase HIV risk. The goal was to find hidden infections and understand how common they are in a hospital setting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bedside rapid capillary HIV test
What this could lead to
If successful, this could show that routine HIV testing in hospitals helps find hidden cases earlier, leading to better care and reduced spread.
What could go wrong
This is a small, single-center observational study, so results may not apply to other hospitals or populations. It only measures prevalence, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

300 people

The number who actually took part.

Started

Feb 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Individuals admitted to various Units of San Raffaele Hospital (medical or surgical area).

Ages

14 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals admitted to various Units of IRCCS San Raffaele Hospital. * Individuals aged 14 years or older. * Individuals meeting at least one of the following criteria: * Presence of at least one HIV-IC. * Presence of at least one behavioral risk factors for HIV infection. * Individuals providing specific written informed consent for the study, or minors whose parents or legal guardians provide specific written informed consent for the study. Exclusion Criteria: * Individuals not providing specific written informed consent for the study. * Individuals with previously known HIV infection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AIDS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IRCCS San Raffaele Scientific Institute

    Milan, 20127, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.